These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23252396)

  • 1. Haemorrhage and amyloidosis - response to Veneri et al.
    Wettlé C; Springinsfeld G; Lipsker D
    Br J Haematol; 2013 Mar; 160(6):854-5. PubMed ID: 23252396
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemorrhage and amyloidosis.
    Veneri D; Pizzolo G; Bonalumi A; Franchini M
    Br J Haematol; 2013 Mar; 160(6):854. PubMed ID: 23240783
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous haemorrhage induced by minimal trauma as a sign of light chain-associated amyloidosis.
    Wettle C; Springinsfeld G; Lipsker D
    Br J Haematol; 2012 Nov; 159(4):383. PubMed ID: 22957696
    [No Abstract]   [Full Text] [Related]  

  • 4. Bruising and Hemorrhagic Vesicles on the Tongue.
    Taylor NA; Lugo-Somolinos A; Sayed CJ
    JAMA Dermatol; 2016 Feb; 152(2):207-8. PubMed ID: 26509772
    [No Abstract]   [Full Text] [Related]  

  • 5. The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
    Decker I; Goodman SA; Phillips SE; Lenihan DJ; Cornell RF
    Br J Haematol; 2017 May; 177(3):481-483. PubMed ID: 28295184
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy.
    Muchtar E; Buadi FK; Dispenzieri A; Gertz MA
    Acta Haematol; 2016; 135(3):172-90. PubMed ID: 26771835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
    Gertz MA; Comenzo R; Falk RH; Fermand JP; Hazenberg BP; Hawkins PN; Merlini G; Moreau P; Ronco P; Sanchorawala V; Sezer O; Solomon A; Grateau G
    Am J Hematol; 2005 Aug; 79(4):319-28. PubMed ID: 16044444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
    Ravindran A; Grogg KL; Domaas DA; Go RS
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):588-592. PubMed ID: 27600986
    [No Abstract]   [Full Text] [Related]  

  • 9. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
    Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
    Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
    Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoglobulin amyloidosis].
    Hermine O; Bourquelot P; Buzyn A; Aucouturier P
    Rev Prat; 1997 Oct; 47(16):1787-91. PubMed ID: 9453204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
    Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
    J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of abdominal skin plus subcutaneous fat and rectal mucosal biopsy in the diagnosis of AL amyloidosis with renal involvement.
    Li T; Huang X; Cheng S; Zhao L; Ren G; Chen W; Wang Q; Zeng C; Liu Z
    PLoS One; 2017; 12(9):e0185078. PubMed ID: 28926601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-light-chain immunoglobulin amyloidosis: time to expand or refine the spectrum to include light+heavy chain amyloidosis?
    Picken MM
    Kidney Int; 2013 Mar; 83(3):353-6. PubMed ID: 23446254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic challenges of amyloidosis in Waldenström macroglobulinemia.
    Palladini G; Merlini G
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):244-6. PubMed ID: 23474147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, endoscopic, and histopathological features of localized immunoglobulin light chain (AL) amyloidosis in the gastrointestinal tract.
    Katoh N; Matsuda M; Ikeda S
    Amyloid; 2015; 22(4):254-6. PubMed ID: 26403136
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulin light chain amyloidosis.
    Merlini G; Comenzo RL; Seldin DC; Wechalekar A; Gertz MA
    Expert Rev Hematol; 2014 Feb; 7(1):143-56. PubMed ID: 24350907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New possibilities of the diagnosis and monitoring of the course of AL-amyloidosis].
    Rameev VV; Kozlovskaia LV; Kogarko IN; Kogarko BS
    Ter Arkh; 2010; 82(6):29-32. PubMed ID: 20731106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambda light chain deposition disease presenting as an amyloid-like arthropathy.
    Rivest C; Turgeon PP; Senécal JL
    J Rheumatol; 1993 May; 20(5):880-4. PubMed ID: 8336318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
    Cibeira MT; Oriol A; Lahuerta JJ; Mateos MV; de la Rubia J; Hernández MT; Granell M; Fernández de Larrea C; San Miguel JF; Bladé J;
    Br J Haematol; 2015 Sep; 170(6):804-13. PubMed ID: 25974382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.